U.S. COVID-19 Update eNewsletter
November 3, 2021

Which Cancer Patients Are Most at Risk for Severe COVID-19?
COVID-19 patients with recent cancer treatment and COVID-19, especially metastatic solid tumors and hematologic malignant neoplasms, had a dramatically higher risk of adverse outcomes from SARS-CoV-2 infection, according to a recent study. Read more.



Here's How, When to Vaccinate People Eligible for a Fourth COVID-19 Shot
As pharmacists can testify, providing COVID-19 vaccines has become much more complex recently with differences in dosages, wait times, and schedules for boosters. Among the most complicated processes is making sure that immunocompromised patients are adequately protected against SARS-CoV-2, especially given their eligibility for a fourth shot. Here is more information.

Young-Adult Hospitalizations Linked to Vaccine Status, Not Delta Severity
The Delta variant of COVID-19 has proven to be highly transmissible, but a new study suggests that it is not more severe than previous versions. So, why the high hospitalization rate among young adults during that time period? Public-health officials blame too-low vaccination rates. Here are more details.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App